Data from PRX012, PRX005 and PRX123 programs showcase promise of Prothena’s pipeline and commitment to transform the care of patients with Alzheimer s disease
Broad participation at this year's congress highlights Prothena's leadership in advancing next generation treatments for Alzheimer's and Parkinson's disease Oral presentation on PRX012, Prothena's